Virpax Pharmaceuticals (VRPX) Stock Chart & Stock Price History $0.02 +0.00 (+0.50%) As of 03:03 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virpax Pharmaceuticals Stock Price Performance The Virpax Pharmaceuticals (VRPX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.95%, with a year-to-date return of -99.79%. In the past month, the stock has decreased 95.63%, reflecting recent market activity. As of the latest close, Virpax Pharmaceuticals traded at $0.02 with a market cap of $25 thousand and volume of 2,185 shares. Receive VRPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-94.98%1 Month Performance-95.63%3 Month Performance-92.27%Year-To-Date Performance-99.79%1 Year Performance-99.95% VRPX Stock Chart for Thursday, July, 24, 2025 VRPX Chart by TradingView Virpax Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/24/2025$0.02$0.02+0.50%$0.02$0.02658 shs$25,000.0007/23/2025$0.06$0.02-66.44%$0.02$0.012,185 shs$25,000.0007/22/2025$0.33$0.06-81.94%$0.11$0.0158,680 shs$74,000.0007/21/2025$0.40$0.33-17.50%$0.37$0.335,296 shs$410,000.0007/18/2025$0.44$0.40-9.09%$0.43$0.3911,184 shs$497,000.0007/17/2025$0.42$0.44+4.76%$0.46$0.428,903 shs$546,000.0007/16/2025$0.36$0.42+16.34%$0.42$0.3642,123 shs$522,000.0007/15/2025$0.37$0.36-2.46%$0.37$0.362,201 shs$448,000.0007/14/2025$0.35$0.37+4.67%$0.42$0.3614,648 shs$460,000.0007/11/2025$0.33$0.35+7.15%$0.36$0.3311,248 shs$439,000.00 Get the Latest News and Ratings for VRPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/10/2025$0.34$0.33-2.94%$0.36$0.331,694 shs$410,000.0007/09/2025$0.32$0.34+5.62%$0.34$0.3213,549 shs$422,000.0007/08/2025$0.39$0.32-17.46%$0.45$0.3223,096 shs$400,000.0007/07/2025$0.39$0.39+0.26%$0.39$0.3219,498 shs$484,000.0007/04/2025$0.39$0.39$0.46$0.3231,581 shs$483,000.0007/03/2025$0.40$0.39-2.77%$0.46$0.3231,581 shs$497,000.0007/02/2025$0.35$0.40+14.71%$0.44$0.354,271 shs$497,000.0007/01/2025$0.32$0.35+10.38%$0.35$0.321,075 shs$433,000.0006/30/2025$0.32$0.32+0.32%$0.33$0.323,316 shs$392,000.0006/27/2025$0.30$0.32+4.83%$0.32$0.282,385 shs$391,000.0006/26/2025$0.33$0.30-9.43%$0.47$0.2810,062 shs$373,000.0006/25/2025$0.46$0.33-27.87%$0.45$0.339,269 shs$412,000.0006/24/2025$0.28$0.46+64.93%$0.48$0.2867,252 shs$571,000.0006/23/2025$0.25$0.28+11.56%$0.28$0.2817,786 shs$346,000.00 Related Companies SLRX Stock Price Chart TNFA Stock Price Chart ADXS Stock Price Chart BPTH Stock Price Chart ATXI Stock Price Chart ASLN Stock Price Chart OGEN Stock Price Chart EVFM Stock Price Chart NMTR Stock Price Chart TRVN Stock Price Chart Receive VRPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRPX) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
